 
            Broadens the Treatable Patient Population
- Includes both primary and secondary mitral regurgitation patients who are high risk for open-heart surgery 
- Positioned above the native mitral valve, atrial-only fixation ensures critical cardiac structures are retained within the left ventricle 
- AltaValve was engineered to minimize complications sometimes found with other TMVR technologies such as device embolization, left ventricular outflow tract (LVOT) obstruction, left ventricular dysfunction (e.g. chordae tendineae rupture), etc. 
- AltaValve’s stent enables future left atrial access for other procedures 
- AltaValve is the only device designed to treat patients with previous valve repair 
CAUTION -- Investigational device. Limited by Federal (or United States) law to investigational use.
Specifically Designed for Streamlined Transseptal Delivery
- AltaValve is recapturable even after complete deployment, leading to improved procedural safety* 
- The prosthetic valve is fully functional seconds after deployment, ensuring patient’s hemodynamic stability 
- TS Delivery System provides controlled steerability, accommodating a variety of anatomies 
*AltaValve is fully recapturable at any point in the procedure until it is detached from the delivery catheter
 
          
        
       
             
             
            